Profil
Joseph C.
DosSantos worked as Chief Financial Officer at MYOS RENS Technology, Inc. from 2015 to 2016.
He was Chief Financial Officer at CareCloud, Inc. in 2023.
He served as Chief Financial Officer at Luzsana Biotechnology, Inc. from 2021 to 2023.
Mr. DosSantos is expected to be Chief Financial Officer & Senior VP Finance at Celularity, Inc. from 2025 to 2026.
Mr. DosSantos completed an undergraduate degree at Kean University in 1991 and earned an MBA from Seton Hall University.
Ehemalige bekannte Positionen von Joseph C. DosSantos
| Unternehmen | Position | Ende |
|---|---|---|
| CELULARITY INC. | Finanzdirektor/CFO | 27.02.2026 |
| CARECLOUD, INC. | Finanzdirektor/CFO | 10.05.2023 |
Luzsana Biotechnology, Inc.
Luzsana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Finanzdirektor/CFO | 08.05.2023 |
| MEDAVAIL HOLDINGS, INC. | Vorstandsvorsitzender | 17.12.2015 |
Ausbildung von Joseph C. DosSantos
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
MYOS RENS Technology, Inc.
MYOS RENS Technology, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes therapeutic products, nutritional supplements and other technologies | Health Technology |
Kean University
Kean University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University
Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CareCloud, Inc.
CareCloud, Inc. Packaged SoftwareTechnology Services Provides healthcare information technology solutions | Technology Services |
Celularity, Inc.
Celularity, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that discovers cancer sub-types and therapeutic options for cancer patients | Commercial Services |
Luzsana Biotechnology, Inc.
Luzsana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
















